Is Accendra Health Inc (ACH) overvalued? · rev $10.70B
Accendra Health Inc (ACH) is a medical distribution company listed on NYSE.
This page asks whether Accendra Health Inc (ACH) looks expensive on cached numbers — not a short thesis.
Latest reported ACH revenue for 2024-12-31 was $10.70B. Net income was -$362.7M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. ACH currently screens at market cap $237.8M.
ACH currently screens at market cap $237.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ACH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ACH stock page for the full model, not this heading.
Not investment advice.